Versant Ventures
Venture capitalSan Francisco · Series A–Series B · 36 people tracked
Investment thesis
Versant operates discovery engines staffed by multidisciplinary scientists in laboratory facilities to support the founding and launch of novel biotechnology companies with academic founders.
Source: firm website, verified Jul 21, 2026.
Team · 36 people
from the firm's website
What they invest in
from 5 of 6 portfolio companiesBiotech ×5Medical Devices ×4Deep Tech ×3AI & Machine Learning ×1Digital Health ×1
HQs:United States×3Switzerland×1
Investments · 6 tracked
founders shown can be your intro pathCapsida Biotherapeutics develops engineered gene therapies for rare and common neurological and ocular diseases using an AAV capsid platform that enables improved brain and retinal delivery compared to naturally occurring capsids. The company targets both central nervous system and ophthalmology conditions across all ages.
BiotechDeep TechDigital HealthMedical Devices
Viviana GradinaruNick Goeden, Ph.D.(Co-founder)Nicholas Flytzanis(Co-founder)
Gate Bioscience develops small molecule therapeutics called Molecular Gates for disease treatment. The company operates in the drug discovery and development space.
BiotechDeep TechMedical Devices
Jordi Mata-Fink(Chief Executive Officer, Co-Founder)Raman Talwar(Chief Technology Officer, Co-Founder)Pat Sharp(Scientific Founder)
Granite Bio develops first-in-class therapeutic antibodies targeting inflammation, autoimmunity, and fibrosis for patients lacking effective treatment options. The company is based in Basel, Switzerland, with a pipeline including Minokitug for autoimmune inflammation and GRT-002 for allergy and itch conditions.
BiotechMedical DevicesBasel, CH
Patrick Loustau(President and Chief Executive Officer)
Santa Ana Bio develops engineered antibodies targeting immune system pathways to treat autoimmune and inflammatory diseases. The company uses precision therapeutics designed to either suppress overactive immune responses or reactivate dormant ones.
BiotechMedical DevicesAlameda, US
Peter Emtage(Founder & CEO)Alexander Rudensky(Scientific Founder)Richard Flavell(Scientific Founder)Graham Lord(Scientific Founder)
Eye-tracking and human-state platform for clinical and consumer applications.
Vividion Therapeutics develops small molecule therapeutics using a covalent-first chemoproteomics approach to identify and target previously undruggable proteins. The company operates across the full drug development spectrum from discovery to clinical development.
AI & Machine LearningBiotechDeep Tech
Ben Cravatt(Scientific Founder)Phil Baran(Scientific Founder)Jin-Quan Yu(Scientific Founder)
Board seats · per SEC filings · 2
what is this? ⓘ$50.4M raise · filed Jul 2024 · via Carlo Rizzuto, Clare Ozawa, Monal Mehta
$150.7M raise · filed Mar 2021 · via Carlo Rizzuto, Jerel Davis
Inferred from directors named on each company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Versant Ventures invest at?
- Versant Ventures invests at the Series A, Series B stages.
- What sectors does Versant Ventures focus on?
- Versant Ventures focuses on Biotech.
- Where is Versant Ventures located?
- Versant Ventures is headquartered in San Francisco, US.
Images
Similar investors
a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz that invests in seed through growth-stage technology companies across multiple sectors including AI, healthcare, consumer, crypto, enterprise, fintech, and gaming. The firm manages over $100 billion in assets and operates a distinctive platform model with a large team of operators supporting founders throughout their journey.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Bessemer Venture Partners is a venture capital firm with a 50-year history supporting entrepreneurs in building enduring companies globally. The firm draws on deep operational expertise and advisory relationships to support portfolio companies through their growth journey.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.